Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers

NCT01353144 ·Status: COMPLETED ·Phase: PHASE4

Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation

NCT01051388 ·Status: COMPLETED ·Phase: PHASE3

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

NCT01456247 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

NCT01452763 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

NCT00125736 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

NCT01397448 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

NCT00839306 ·Status: COMPLETED ·Phase: PHASE3

Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users

NCT03962283 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

NCT04494243 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole

NCT04622358 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

NCT00762359 ·Status: TERMINATED ·Phase: PHASE3

Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

NCT01069939 ·Status: COMPLETED ·Phase: PHASE3

Nexium Capsules LDA Specific Clinical Experience Investigation

NCT01729182 ·Status: COMPLETED

Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers

NCT00838682 ·Status: TERMINATED ·Phase: PHASE4

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

NCT00542789 ·Status: COMPLETED ·Phase: PHASE3

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

NCT00595517 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control

NCT00713947 ·Status: WITHDRAWN ·Phase: PHASE4

Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel

NCT00989300 ·Status: COMPLETED ·Phase: PHASE1

To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

NCT01249651 ·Status: COMPLETED ·Phase: PHASE4

Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection

NCT02541786 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

NCT01202071 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

NCT02509923 ·Status: COMPLETED ·Phase: PHASE1

Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT

NCT02166008 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury

NCT01140828 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

NCT02418312 ·Status: COMPLETED ·Phase: NA